Serge Saxonov - 12 Dec 2022 Form 4 Insider Report for 10x Genomics, Inc. (TXG)

Role
Chief Executive Officer, Director
Signature
/s/ Eric S. Whitaker, as Attorney-in-Fact for Serge Saxonov
Issuer symbol
TXG
Transactions as of
12 Dec 2022
Net transactions value
+$3,600
Form type
4
Filing time
14 Dec 2022, 15:35:13 UTC
Previous filing
23 Nov 2022
Next filing
24 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TXG Class A Common Stock Options Exercise $3,600 +3,000 +0.33% $1.20* 911,656 12 Dec 2022 Direct F1
transaction TXG Class A Common Stock Gift $0 -1,740 -70% $0.000000 747 13 Dec 2022 See footnote F2
holding TXG Class A Common Stock 145,960 12 Dec 2022 See footnote F3
holding TXG Class A Common Stock 870 12 Dec 2022 See footnote F4
holding TXG Class A Common Stock 9,400 12 Dec 2022 See footnote F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TXG Stock Option (right to buy) Options Exercise $0 -3,000 -7.3% $0.000000 38,035 12 Dec 2022 Class A Common Stock 3,000 $1.20 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Excludes 870 shares transferred to Sirius Trust, 9,400 shares transferred to Y/S Pot Trust and 56,000 shares transferred to the Y/S Descendants' Trust, on December 13, 2022.
F2 The shares are held by the Andromeda Trust, for which the Reporting Person serves as trustee.
F3 The shares are held by the Y/S Descendants' Trust, for which the Reporting Person serves as trustee.
F4 The shares are held by the Sirius Trust, for which the Reporting Person serves as trustee.
F5 The shares are held by the Y/S Pot Trust, for which the Reporting Person serves as trustee.
F6 This option, originally for 300,000 shares, of which 261,965 have been exercised, vested as to 1/48th of the shares on October 1, 2017, and 1/48th of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.